BackCymabay Therapeutics Overview

Cymabay Therapeutics Research & Development

Research & Development expenses for CBAY.

Quarterly R&D Expenses

$22.69M
↑ 39.82% YoY

As of Dec 31, 2023

Annual R&D Expenses (TTM)

$80.74M
↑ 18.75% YoY

Trailing 12 months ending Dec 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin